来自专业的译者、企业、网页和免费的翻译库。
cysteamine (mercaptaminebitartraat)
cysteamine (mercaptamine bitartrate)
最后更新: 2017-04-26
使用频率: 1
质量:
het werkzame bestanddeel is cysteaminebitartraat (mercaptaminebitartraat).
the active substance is cysteamine bitartrate (mercaptamine bitartrate).
最后更新: 2017-04-26
使用频率: 3
质量:
elke capsule bevat 25 mg cysteamine (als mercaptaminebitartraat).
each capsule contains 25 mg of cysteamine (as mercaptamine bitartrate).
最后更新: 2017-04-26
使用频率: 2
质量:
elke harde capsule bevat 150 mg cysteamine (als mercaptaminebitartraat).
each hard capsule contains 150 mg of cysteamine (as mercaptamine bitartrate) .
最后更新: 2017-04-26
使用频率: 6
质量:
iedere harde capsule bevat 150 mg cysteamine (als mercaptaminebitartraat).
each hard capsule contains 150 mg of cysteamine (as mercaptamine bitartrate) for a full list of excipients, see section 6.1.
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
elke harde cystagon 150 mg capsule bevat 150 mg cysteamine (als mercaptaminebitartraat).
cystagon 50 mg contains 50 mg of cysteamine (as mercaptamine bitartrate) each hard capsule of cystagon 150 mg contains 150 mg of cysteamine (as mercaptamine bitartrate)
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
cystagon 50 mg harde capsules cystagon 150 mg harde capsules cysteaminebitartraat (mercaptaminebitartraat)
cystagon 50 mg hard capsules cystagon 150 mg hard capsules cysteamine bitartrate (mercaptamine bitartrate)
最后更新: 2017-04-26
使用频率: 1
质量:
informatie voor de gebruik(st)er cystagon 50 mg harde capsules cystagon 150 mg harde capsules cysteaminebitartraat (mercaptaminebitartraat)
cystagon 50 mg hard capsules cystagon 150 mg hard capsules cysteamine bitartrate (mercaptamine bitartrate)
最后更新: 2012-04-11
使用频率: 2
质量:
op basis van de wetenschappelijke conclusies voor cystagon is het chmp van mening dat de baten- risicoverhouding van het (de) geneeskundige product(en) dat (die) de werkzame stof mercaptaminebitartraat bevatten, gunstig is behoudens de voorgestelde veranderingen in de productinformatie.
on the basis of the scientific conclusions for cystagon the chmp is of the opinion that the benefit- risk balance of the medicinal product(s) containing the active substance mercaptamine bitartrate is favourable subject to the proposed changes to the product information.
最后更新: 2017-04-26
使用频率: 1
质量: